Susquehanna International Group, LLP Cardiol Therapeutics Inc. Call Options Transaction History

Susquehanna International Group, LLP

  • $560 Billion
  • Q3 2024

Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 15, 2024
BUY
$1.67 - $2.97 $158,650 - $282,150
95,000 Added 250.0%
133,000 $268,000
Q1 2024

May 07, 2024
BUY
$0.88 - $2.06 $18,128 - $42,436
20,600 Added 118.39%
38,000 $68,000
Q4 2023

Feb 14, 2024
BUY
$0.67 - $1.0 $11,658 - $17,400
17,400 New
17,400 $14,000
Q1 2022

May 16, 2022
SELL
$1.25 - $2.31 $37,875 - $69,993
-30,300 Reduced 25.83%
87,000 $134,000
Q4 2021

Feb 14, 2022
BUY
$1.83 - $4.86 $214,659 - $570,078
117,300 New
117,300 $217,000

Others Institutions Holding CRDL

# of Institutions
45
Shares Held
5.07M
Call Options Held
5.2K
Put Options Held
9.5K
View Full List

About Cardiol Therapeutics Inc.

CRDL Quotes by TradingView
  • Ticker CRDL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 61,942,500
  • Market Cap $98.5M
  • Description
  • Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product is CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate t...
More about CRDL
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email